Get started
Author

Adam H. Fox

Observed names: ADAM FOX, Adam Fox, Adam H Fox
ORCID: 0000-0002-5547-8285
Observed ORCID: 0000-0002-5547-8285
OpenAlex ID: A5074580073
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide
2023 · Adam H. Fox, Mizuki Nishino, et al. · CA A Cancer Journal for Clinicians · 57
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer
2021 · Adam H. Fox, James R. Jett, et al. · CHEST Journal · 32
The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non–small cell lung cancer
2024 · Sinchita Roy‐Chowdhuri, Haresh Mani, et al. · Cancer · 18
PDF
The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancer
2024 · Adam H. Fox, Raymond U. Osarogiagbon, et al. · Cancer · 16
PDF
Outcomes After Surgical Management of Early-Stage Lung Cancer in Octogenarians: An In-Depth Analysis of a Nationally Representative Cohort
2025 · Ian C. Bostock, Adam H. Fox, et al. · Journal of Thoracic Oncology · 15
Approaches to lung nodule risk assessment: clinician intuition versus prediction models
2020 · Adam H. Fox, Nichole T. Tanner · Journal of Thoracic Disease · 14
PDF
First in Human Evaluation of a Novel Thin Convex Probe Endobronchial Ultrasound System
2024 · Nicholas J. Pastis, Vidhya Y. Aroumougame, et al. · Respiration · 11
Biomarker Testing for Guiding Precision Medicine for Patients With Non-Small Cell Lung Cancer
2024 · Adam H. Fox, Mariam Alexander, et al. · CHEST Journal · 10
Pulmonologists’ Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer
2024 · Adam H. Fox, Mark A. Rudzinski, et al. · CHEST Journal · 9
PDF
Turnaround Time of Comprehensive Genomic Profiling in Lung Cancer and Other Solid Tumors
2026 · Adam H. Fox, Rachel B. Keller-Evans, et al. · JCO Oncology Practice · 3
PDF
Rates of Systemic Treatment for Metastatic Non–Small Cell Lung Cancer Among Older Adults
2026 · Adam H. Fox, Ralph C. Ward, et al. · JAMA Oncology · 3
Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons
2025 · Ian C. Bostock, Adam H. Fox, et al. · The Annals of Thoracic Surgery · 1
Real-world analysis of factors influencing turnaround time (TAT) for tissue comprehensive genomic profiling (CGP) in non-small cell lung cancer (NSCLC).
2025 · Adam Fox, Rachel B. Keller-Evans, et al. · Journal of Clinical Oncology · 1
PDF
Molecular biomarkers for the evaluation of indeterminate pulmonary nodules: a systematic review
2026 · Kathryn J Long, Adam H Fox, et al. · Annals of the American Thoracic Society
State Variation in the Incidence of Small Cell Lung Cancer and Its Association With Smoking
2026 · Kalyani Sonawane, Ashvita Garg, et al. · CHEST Journal
PDF
Pulmonary Lesion Location Within the Inner, Middle, and Outer Thirds of the Hemithorax: the Imo Trial
2024 · VIDHYA AROUMOUGAME, CHRISTOPHER R GILBERT, et al. · CHEST Journal
PDF
Health Care Provider Practices and Perceptions of Biomarker Testing in US Veterans With Non-Small Cell Lung Cancer
2024 · Elena Vlachos, Adam Fox, et al. · CHEST Journal
PDF
Pilot Data on the Adequacy for Next Generation Sequencing in Ebus-tbna Specimen Vs Liquid Biopsies in Patients With Non-small Cell Lung Cancer (nsclc)
2023 · TRAVIS L FERGUSON, JEFFREY THIBOUTOT, et al. · CHEST Journal
PDF
Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-small Cell Lung Cancer
2023 · ADAM FOX, MARK RUDZINSKI, et al. · CHEST Journal
Works count: 19
Citation count: 190
H-index: 9
I10-index: 8
Year
Topic
Type